The angiotensin II type 1 receptor blocker losartan attenuates bioprosthetic valve leaflet calcification in a rabbit intravascular implant model.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Journal of Cardio-Thoracic Surgery

• Publication date

  2016-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ejcts/ezw191PMID 27261074
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Degenerative Calcification of Pericardial Bioprostheses: Comparison of Five Implantation Methods in a Rabbit Model.

  2015cited by this paper
• Angiotensin Receptor Blockers Are Associated with Reduced Fibrosis and Interleukin-6 Expression in Calcific Aortic Valve Disease

  2013cited by this paper
• Impact of telmisartan on the inflammatory state in patients with coronary atherosclerosis--influence on IP-10, TNF-α and MCP-1.

  2013cited by this paper
• Effect of Angiotensin II Type 1 Receptor Antagonist, Losartan on Inflammatory Factor in Atherosclerotic Rabbits

  2013cited by this paper
• Human Mast Cells (HMC-1 5C6) Enhance Interleukin-6 Production by Quiescent and Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells

  2012cited by this paper
• Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations

  2011cited by this paper
• Detoxification of Glutaraldehyde Treated Porcine Pericardium Using L-arginine & NABH4

  2011cited by this paper
• Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves

  2011cited by this paper
• Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease.

  2011cited by this paper
• Angiotensin II type 1 receptor blocker inhibits arterial calcification in a pre-clinical model.

  2011cited by this paper
• Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation

  2010cited by this paper
• Mid-term results of the Hancock II valve and Carpentier-Edward Perimount valve in the pulmonary portion in congenital heart disease.

  2010cited by this paper
• Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients.

  2010cited by this paper
• Prosthetic Heart Valves: Selection of the Optimal Prosthesis and Long-Term Management

  2009cited by this paper
• Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits.

  2007cited by this paper
• Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more).

  2006cited by this paper
• Angiotensin-converting enzyme inhibitors and change in aortic valve calcium.

  2005cited by this paper
• Calcification of tissue heart valve substitutes: progress toward understanding and prevention.

  2005cited by this paper
• Targeted therapy to prevent progression of calcific aortic stenosis.

  2004cited by this paper
• Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism.

  2003cited by this paper
• Bioprosthetic tissue calcification: influence of blood contact and arterial pressure. an experimental study in rats and sheep.

  2003cited by this paper
• Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma

  2002cited by this paper
• Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves.

  1997cited by this paper
• Prevention of leaflet calcification of bioprosthetic heart valves with diphosphonate injection therapy. Experimental studies of optimal dosages and therapeutic durations.

  1987cited by this paper
• Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate.

  1985cited by this paper
• Inhibition by diphosphonate compounds of calcification of porcine bioprosthetic heart valve cusps implanted subcutaneously in rats.

  1985cited by this paper

• Comparative Investigation of the Effects of Entelon150®, Losartan, and Rosuvastatin Following Subdermal Valve Prosthesis in a Rat Model.

  2026cites this paper
• Perioperative management and inflammatory marker monitoring in a cardiac surgery patient treated with tocilizumab: a case report of successful surgical aortic valve replacement

  2025cites this paper
• Entelon150® (Vitis vinifera Seed Extract) Attenuates Degenerative Changes in Intravascular Valve Prostheses in Rabbits

  2023cites this paper
• ) reduces

  2023cites this paper
• Local Renin-Angiotensin System Signaling Mediates Cellular Function of Aortic Valves

  2021cites this paper
• Entelon (vitis vinifera seed extract) reduces degenerative changes in bovine pericardium valve leaflet in a dog intravascular implant model

  2021cites this paper
• Entelon® (vitis vinifera seed extract) reduces inflammation and calcification in a beagle dog model of intravascular bovine pericardium implantation

  2020cites this paper
• Sex-related Differences in Calcific Aortic Valve Stenosis: Pathophysiology, Epidemiology, Etiology, Diagnosis, Presentation, and Outcomes

  2018cites this paper
• Roles and possible mechanisms of autoantibodies against the angiotensin AT1 receptor in vascular calcification of rats.

  2018cites this paper